Top Dividend Stock #8: Pfizer (PFE)
Dividend Yield: 3.23%
YTD Performance: +5.06%
52-Week Return: +14.85%
Pfizer (PFE) has once again taken the No. 8 spot in our latest installment of the top Dow dividend stocks. With a market capitalization of more than $200 billion, PFE is the world’s biggest pharmaceutical company, earning approximately 90% of its revenues from the sale of its prescription drugs, such as Viagra and Lyrica.
PFE did lose its patent for the popular cholesterol medication Lipitor, but it is currently in the process of commercializing an over-the-counter version of the drug, and the company has been able to make up for any losses by increasing sales of their current stable of drugs. Also, shares have been buoyed by better-than-expected data from a new study of their pneumonia vaccine, as well as a new cardiovascular medication called Eliquis.
Despite the loss of exclusivity rights for the major drug, PFE is still projecting sales to be upwards of $50 billion in 2014 on the high end of the range. The company continues to show strong growth prospects, and with its latest 8.3% distribution increase to 26 cents per share per quarter, owners of the stock are looking at a $1.04 annual payout going forward.